Balansag, Rodelia B.

HRN: 08-69-08  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/16/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
09/16/2025
09/22/2025
IV
2.25gm
Q8
Infected Wound
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines